Melanotan 1: identity, aliases and research context
Resolve Melanotan I, NDP-MSH and afamelanotide naming while keeping molecular identity separate from a licensed implant formulation.
Read the article →Research Hub
Explore peptide science, analytical testing and the documentation behind research materials.
500 articles to explore
Melanotan 2: identity and research context
Identify the cyclic Melanotan II structure and distinguish early pigmentation and erectile-response studies from broad safety or product claims.
Read the article →MOTS-c: identity and research context
Follow MOTS-c from mitochondrial sequence discovery to experimental metabolism studies, without confusing human exercise observations with peptide treatment.
Read the article →NAD+: coenzyme identity and research context
Identify NAD+ as a nucleotide coenzyme and distinguish direct NAD+ studies from research on precursor molecules.
Read the article →PT141: identity, aliases and research context
Connect PT-141 with bremelanotide while preserving the formulation, study population and endpoint behind each clinical finding.
Read the article →Sermorelin: identity and research context
Identify sermorelin as GHRH(1–29) amide and avoid assigning findings from substituted analogues to the unmodified sequence.
Read the article →SS-31: identity, aliases and research context
Connect SS-31 and elamipretide while separating membrane experiments, mitochondrial-myopathy trials and the specific Barth syndrome development programme.
Read the article →Tesamorelin: identity and research context
Identify tesamorelin’s modified 44-residue structure and interpret its visceral-fat studies within the population and formulations actually investigated.
Read the article →Thymosin Alpha 1: identity and research context
Identify the acetylated 28-residue peptide, distinguish thymosin mixtures and combinations, and read the corrected TESTS trial accurately.
Read the article →Bacteriostatic water: formulation identity and documentation
Identify the exact preserved-water formulation and document its manufacturer, ingredients and intended scope without assuming universal compatibility.
Read the article →Thymosin Beta 4: a reference for interpreting fragment research
Use full-length thymosin beta-4 as a structural and experimental reference without assuming its fragments reproduce the same actin-related activity.
Read the article →ACTH fragments: why residue boundaries matter in research
Map ACTH fragment numbers to actual sequences and distinguish native segments from modified analogues before comparing their studies.
Read the article →